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Abstract
Cost comparative analysis of two-tiered and multi-tiered approaches to MRI for multiple
sclerosis and prostate cancer
Farshad Safaei Ardakani
Every year, a vast amount of money is spent across Canada for healthcare. In fact, Canada
healthcare system has been spending more than numerous other countries, yet the outcome is not
proportional to the efforts and budget that have been used. A big chunk of the pie of expense sur-
plus comes from over-utilization of resources. Most notably, around 20 % to 50 % of this cost
stems from the high-tech imaging modality, especially MRI scanners. This over-utilization in MRI
procedures leads to higher costs for the system and patients, longer waiting time, and patients’
dissatisfaction. Researchers have developed methods to improve patient experience and the popu-
lation’s health while reducing the per capita cost of healthcare. Motivated by the mentioned facts,
the primary purpose of this thesis is to compare two-tiered and multi-tiered approaches to MRI for
the diagnostics of multiple sclerosis (MS) and prostate cancer (PC) diagnosis in a community-based
practice in a large metropolitan area in Canada. The goal is to identify the best procedure protocol
in terms of cost, efficiency and throughput. In particular, our contributions are two-fold. First, we
compare different MRI procedures to MS diagnostics based on referring physician specialization
(i.e. neurologists and non-neurologists referrals). We further investigate the dependency between
the test results and referral pattern via conducting a statistical hypothesis test. Our second contri-
bution revolves around the comparison between two-tiered and multi-tiered MRI procedures for PC
diagnostics in terms of cost and efficiency. Through a decision tree analysis, we demonstrate that
two-tiered MS MRI approach and two-tiered MpMRI for PC turns out to be the most cost efficient
methods with the lowest number of adverse events while improving patients experience through
reducing the number of callbacks and venipuncture/contrast complications.
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In This chapter, we first present motivation of this study. Afterwards, we clarify the objectives
and finally, state the outlines of this thesis.
1.1 Motivation
Studies around healthcare services have grown recently due to the lack of efficiency in this
sector. Canada healthcare services have been spending more than most of the other countries; Total
health expenditure is expected to reach $253.5 billion or $6,839 per capita in 2018 (OECD, 2019);
yet the outcome is not meeting the expectations compared to other countries, (Erickson, Rockwern,
Koltov, & McLean, 2017), (Hovanesyan, Rubio, Novak, Budoff, & Rich, 2017).
Since the establishment of Medicare in the 1960s, Canada’s health care system has experienced
an ongoing continuous period of growth. The only exception was this growth in the early to mid-
1990s, when federal and provincial governments faced a reduction in budget deficits. The ratio of
health to GDP is estimated to be 11.3% in 2018 (CIHI, 2018). With an increase in real costs of
more than 10% per annum for nearly a decade, health care costs rise to their highest historical level
- in absolute dollars or percentage of GDP.
According to (CIHI, 2018), while growth in health care costs has been observed in all sections,
yet the highest percentage increase is not in traditional medical services and hospitals. Together,
these two sectors dropped according to the percentage of public health care spending in Canada
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from 74.7% in 1975 to 51.4% in 2018. Decreasing cost proportions in these two main areas has
been described with growth in areas such as medicine, home care, public health and diagnostic
services.
There are many explanations for the higher costs such as health insurance, administrative costs,
prescription drugs and diagnostic testing; yet the most important contributor to the cost of healthcare
is over-utilization. This over-utilization has two sides: 1) The high volume of services such as
hospitalization, office visits, tests and procedures; and 2) Expensive tests, and procedures (Emanuel
& Fuchs, 2008).
Advanced medical technologies bring higher cost of services. Accordingly, the primary driver of
healthcare costs in developed countries are medical technologies such as medical imaging. During
the past decade, the cost of medical imaging has grown twice the rate of other technologies in
healthcare sector. The demands and benefits of medical imaging are unquestionable, but some
publications have suggested that around 20%-50% of these high-tech imaging procedures cannot
provide the information that can improve patient welfare or reduce the treatments procedure and
therefore might be unnecessary and lead to the over-utilization of the MRI scanners, doctors, and
specialists (Hendee et al., 2010), (Iglehart, 2006).
Among different medical imaging technologies, magnetic resonance imaging (MRI) is the pri-
mary diagnostic procedure for multiple sclerosis (MS) and prostate cancer (PC). MRI is a medical
imaging system utilized in radiology to form detailed images of the anatomy and the physiological
processes of the body (Smith-Bindman et al., 2012).
Studies from different provinces indicate that the prevalence of multiple sclerosis (MS) among
Canadians is one of the highest in the world. The estimation of Canadians reported a diagnosis of
MS is 93,500 based on the most recent data in 2011. Women are more likely to have MS compared
to men, around two to three times. This imbalance in the sex ratio is increasing in several countries.
In Canada, there are 2.6 women diagnosed with MS for every man with the same condition,leading
to the prevalence estimates of 419 cases per 100,000 women and 159 cases per 100,000 men.
The most observed cancer in men is prostate cancer (161,360 out of 836,150 cases per year).
The death rate of cancer is 1650 per day for men. Detection of cancer in early stages increases
the potential of effective medical treatment. Although it is an vital part of medical care, early
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detection is still challenging (de Rooij, Hamoen, Fu¨tterer, Barentsz, & Rovers, 2014). For public
health, prostate cancer (PC) costs $ 12billion per year, considering 200,000 new cases each year
in the United States. Roughly $ 4.8 billion of cost is related to overestimation of cancer treatment
and cancer detection (Merrill & Stephenson, 2000). There is no precise study of overestimation
and over-treatment of the prostate cancer; however, it is estimated to be around 17 % to 50 % of
screening results.
There are different protocols of diagnosing the disease for both MS and PC MRI procedures. In
Canada, brain MRI imaging can be conducted without pre-authorization or referral from a neurolo-
gist. After a departmental utilization review, it is observed that only a small portion of positive scans
in MRIs, performed for assessment of MS, referred by non-neurologists. For PC MRI procedure, a
full MRI test or abbreviated MRI test can be performed. The advantages of the abbreviated test are
the lower price and shorter period for performing the test. However, there is a disadvantage for this
test, which is of lower accuracy in categorizing the results.
One well-known way to study the cost of medical imaging is Comparative Effectiveness. Com-
parative Effectiveness research means to objectively compare the results of one approach to man-
aging a surgical procedure, disease, or technical procedure or test with another one. By comparing
two (or more) approaches the cost of the system can be reduced, the efficiency can be improved,
while managing the utilization (Hendee et al., 2010).
1.2 Objectives
The primary purpose of this study is to compare different diagnostic protocols for MS MRI
diagnosis and PC MRI diagnosis to find out the best procedure protocol in terms of cost (to the
healthcare system and patient), efficiency and throughput. In particular, we aim to investigate:
1. The comparison between different MRI procedures based on different referring physician
specialization (i.e. neurologists and non-neurologists) in a community-based practice in a large
metropolitan area in Canada. Our goal is to compare the cost, efficiency, and throughput of different
MRI procedures for diagnosing MS. We also aim to conduct a statistical test on the data to assess
the dependency of the results.
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2. The comparison between different MRI procedures for PC diagnostics in a community based
in a large metropolitan area in Canada. Our goal is to compare the cost, efficiency, and throughput
of different MRI procedures for diagnosing PC.
1.3 Thesis outline
To provide the relevant context, the rest of the thesis is organized as follows:
Chapter 1 provides an overview and a summary of the significant contributions made in the
thesis.
Chapter 2 presents a comprehensive background and literature review on Comparative effec-
tiveness analytic and two-tiered approaching for MRI applications, as well as their modules and the
corresponding processing methods.
Chapter 3 introduces the definition of the diseases (MS and PC) as well as the diagnostic proce-
dure of both diseases.
Chapter 4 provides the statistical test of dependency related to referral pattern.
Chapter 5 describes the data collection, methodology and results for our first objective, which
is a comparison of different MRI procedures for diagnosing MS.
Chapter 6 describes the data collection, methodology and results for the second objective, which
is comparison of different MRI procedures for diagnosing PC.




In this chapter, we review studies and researches related to the comparison of different MRI
procedures. Afterwards, the gaps in the existing studies are presented.
With the goal of reducing MRI utilization for patients with low back pain, (Fried, Andrew,
Ring, & Pastel, 2018) proposed the inclusion of a simple epidemiologic statement in MRI reports.
They compared treatment utilization rates between patients whose radiology reports for MRI low
back included the statement with those whose reports did not include the statement. The studied
population was patients with lumber MR imaging. They compared baseline patient characteristics
by performing Pearson Xˆ2 tests for categorized variables and a t-test for age at index MR imaging.
For other characteristics such as sex, low back pain weakness and numbness, the severity of findings
at MR images, a log-binomial test was used.
There is a vast emerging literature favouring the adoption of two-tiered MRI protocols based on
patient population data. (Sharma et al., 2013) compared the diagnostic efficiency and potential cost
implications of conventional and two-tiered MRI approaches in the management of patients with
headache. They apply a two-tiered to increase the efficiency of utilization of the scanner, reduce
the cost and to have less burden on patients. They study the feasibilities and implications from
the patient, payer and imaging facility perspective. They calculated sensitivity and specificity for
two-tiered and conventional MRI and using Fisher exact two-tailed test as independence test.
In (Sharma et al., 2014), the comparison of comprehensive MRI and T2-weighted imaging have
been investigated with the same approaches as (Sharma et al., 2013). In the paper, a decision tree
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was developed to compare the cost-effectiveness of a proposed two-tiered model with conventional
MRI. In the two-tiered strategy, the comprehensive MRI involved only as a second step. They
hypothesized that utilization of proposed two-tiered MRI has significant cost saving with highly
similar results as comprehensive MRI.
Recent studies have shown that abbreviated protocol (AP) of MRI is helpful for detection of
breast cancer. The results also proved that the performance of AP outperforms mammography
(MG).CT scan and MRI has been used to detect acute appendicitis in children. Given the recent
concerns regarding ionizing radiation in CT and being time-consuming and requiring the use of
sedation or anesthesia for traditional MRI, (Zens et al., 2018) developed a quick MRI abdomen
and pelvis protocol without the using of contrast or demand for sedation. The purpose of the study
was to describe the quick MRI as a fast, cost-effective and accurate alternative to CT and traditional
MRI for evaluation of postoperative abscess (POA). The subjects of this study were children under
age of 18 diagnosed with acute appendicitis that required cross-sectional imaging to evaluate for
the presence of am intra-abdominal fluid collection. The chi-squared and independent t-tests with p
values less than 0.05 were used as the test of independence.
(Chen, Huang, Shen, Liu, & Xu, 2017) investigated the usefulness and economical aspects of
using AP compared to a full diagnostic protocol (FDM). The study included data of 356 women
who had dense breast examined. They used one-way analysis of variance to assess differences of
interpretation time and McNemar’s test was used to assess differences of sensitivity and specificity.
(Strahle et al., 2017) tried to reduce the cost and increase the efficiency by developing a sys-
tematic process at defining the appropriate type and number of acquisitions for breast MRI. They
evaluated a full diagnostic protocol (FDP) breast MRI and used the information to develop an ab-
breviated protocol for breast cancer screening. The purpose of the study was maximizing lesion
detection while reducing the cost. The statistical population was all women who obtained their
mammograms between 2009 and 2011 at a community hospital. T-test and Wilcoxon test were used
to compare the stats for a given acquisition.
(Kuhl et al., 2014) has shown that the usage of the abbreviated protocol is a suitable option in
women with the high risk of breast cancer. The authors demonstrated that studies the abbreviated
protocol does not compromise the sensitivity and specificity relative to the conventional complete
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protocol. (Oldrini, Derraz, Salleron, Marchal, & Henrot, 2018) compared the diagnostic accuracy
of the complete protocol to an abbreviated protocol with the usage of the breast imaging reporting
and data system classification for the interpretation time of breast MRIs regardless of the indication
for examination. They also studied between-reader variability and influence of reader expertise on
diagnostic accuracy.
To minimize and eliminate long term disability of patients who have suffered an ischemic stroke,
Intravenous tissue plasminogen activator (IV-tPA) has been widely used in North America. Nev-
ertheless, studies have shown that this treatment may increase the cost of tPA, hospitalization, and
post-IV-tPA in the health care system. Head CT and comprehensive brain MRI have been used
to choose patients eligible for IV-tPA. (Paolini et al., 2013) studied the evaluation of rapid Brain
Attack Team (BAT) MRI as a clinical tool in selecting patients for IV-tPA administration with an
unclear diagnosis or inconsistent stroke-like symptoms.
The existing gaps in the literature
1. There is no prior study that investigates the relation between the incidence of MS with
the referring physician specialization. In particular, among studies that conduct comparative cost
analysis in the content of MS MRI protocols, none has investigated more complicated scenarios
such as the one that choice of MRI procedure depends on the referral pattern.
2. Only a handful of studies compare the cost of different MRI protocols from the perspective
of patients.
3. Mapping different MRI procedures and calculating the throughput of the system have only
been investigated in a few studies.
4. There is no prior study on conducting comparative cost analysis on different PC MRI proce-
dures and consequently mapping those protocols.
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Chapter 3
Definition of the disease and Diagnostic
procedure
This chapter explains the characteristic of MS and PC, followed by elaborating on different MRI
tests designated for their diagnostics.
3.1 Multiple sclerosis (MS)
MS is a progressive disease that potentially debilitates the central nervous system and causes
damage to the myelin, the protective layer around the nerves as it is shown in Figure 3.1 (Ropper et
al., 2014). This brain disorder causes symptoms such as visual impairment, loss of coordination and
balance, severe fatigue, bladder dysfunction, stroke, numbness, weakness, and also mood change.
The nature of symptoms varies and may be characterized by periods of relapse. In most countries
like Canada, MS is usually diagnosed before the age of 50. Most of the household residents with
the age of 15 or more reporting MS had been diagnosed at ages 20 to 49 (95% CI: 75.9 to 86.5).
The average age for people to have their first symptoms experience was 32 with a diagnosis about
five years later by age 37 (Gilmour, Ramage-Morin, & Wong, 2018).
The lives of most of the people diagnosed with MS is significantly affected by the disease.
About two-thirds of them reported that MS changed their life fairly, quite a bit, or extremely. The
remaining third stated that their lives are only slightly affected. Although 57% of MS patients
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Figure 3.1: Myelin damage and the nervous system (Ropper et al., 2014)
may walk without help, about one third (31%) needs a wheelchair, a mechanical aid like a cane
or walker, or another person’s support, 12% could not walk at all. Only More than half (53%)
are usually pain-free, but the rest reported pain that prevented multiple activities (21%) or some
activities (25%). Almost two-third (62%) have trouble sleeping at night. About a third reported
that MS prevented driving (30%) or endangered their educational opportunities (32%). More than
half (58%) have experienced at least some restrictions on job opportunities; 44% described these
limitations as ”very little” or ”severe.” 43% also reported that MS had a negative impact on their
social interactions. For example, they feel embarrassed or perceived that others feel uncomfortable
or avoid them (Gilmour et al., 2018).
3.1.1 MRI procedure for the diagnostic MS
MS usually has a non-specific neurological impairment with a critical period: the gap between
the symptoms of diagnosis and the diagnosis is longer for those who show signs at an earlier age.
The gap is reported as 5.4 years as compared with 2.6 years for men. However, in 2010, McDonald’s
MRI Criteria were revised to detect MS with a single contrast-enhanced (C+) MRI scan in the
appropriate clinical setting. Accordingly, the recommended MRI protocol currently includes at
9
Figure 3.2: C+ MRI for diagnosing MS
least 3-dimensional (3D) T1 weighted, 3D T2 fluid attenuated inversion-recovery (FLAIR), 3D T2
weighted, and pre- and post-single-dose, gadolinium T1 weighted imaging (Polman et al., 2011).
The objective of C+ MRI test is to detect and restrict the brain for any abnormality related to
MS. For this test, patients are required two visits to the hospital, one for the renal function testing
and one for the MRI examination. The renal function test is a requirement prior to IV contrast
injection. C+ MRI is summarized in Figure 3.2. C+ brain MRI is a reliable test to diagnose MS.
However, it has some drawbacks including long time, high cost, and contrast injection which brings
some discomfort and stress to patients. MRI imaging results are divided based on final reports’
conclusion/impression into three ordinal categories:
1) Normal (including normal variations): no indication of demyelination
2) Abnormal, not MS: abnormal findings, non-specific to demyelination or non-specific findings
unrelated to symptoms (incidental findings)
3) Abnormal, suspicious for MS: findings suspicious or typical to demyelinating disease.
It should be noted that categories 2 and 3 do not mean excluding or establishing a diagnosis
of MS; they rather indicate the need for further investigation. A binary “result” is then defined
by classifying the first two categories (Normal and Abnormal, not MS) as Negative and the third
category (Abnormal, suspicious for MS) as Positive.
There is an increasing body of evidence supporting use of targeted, focused, and abbreviated
10
Figure 3.3: Two-tiered MRI for diagnosing MS
MRI protocols in various patient sub-populations based on patient characteristics or disposition
(e.g. outpatients with headache, suspected stroke in emergency room). This decision was later
reinforced by publication of the first article on two-tiered MRI approach in 2014 and has remained
in place ever since (Sharma et al., 2014).
This approach was proposed to reduce the negative affects of C+ brain MRI on healthcare
service and patients experience. In this approach, all patient would undergo an abbreviated non-
contrast brain MRI (C-). If MRI result is negative, MS imaging would be considered complete in a
single hospital visit. If MRI result is positive, patients would enter C+ MRI for an additional two
hospital visits. The two-tiered MRI procedure is illustrated in Figure 3.3.
3.2 Prostate Cancer
With life time risk of 2.8 %, the prostate cancer (PC) is rare before age 50 years old and the
majority of death (around 70%) is related to age 75 or older (Moyer, 2012). PC begins when cells
in the prostate gland start to grow uncontrollably. Prostate is an organ in the men’s reproductive
system. Most of the semen that carries the sperm is made by prostate. It is located under the bladder
and surrounds the upper part of the urethra, the organ that carries urine from the bladder. The
prostate is splitted into four zones as depicted in Figure 3.4 (Sathianathen et al., 2018):
1. The anterior fibromuscular stroma
2. The transition zone (TZ) with 20 % of occurrence of cancers
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Figure 3.4: Prostate Zones (Sathianathen et al., 2018)
3. The central zone (CZ) with 5 % of occurrence of cancers
4. The outer peripheral zone (PZ) with 75 % of occurrence of cancers
Cancers detected in the CZ are rare, and the cancers that occur in the CZ are usually subse-
quent to invasion by PZ tumors. According to (Moyer, 2012), patients after screening usually are
categorized into three cases:
1. The patients with high chance of death without the results of early screening
2. The patients with low chance of death without the results of early testing
3. The patients with decreasing chance of death due to results of screening
3.2.1 MRI procedure for diagnostic PC
One popular screening or testing method for diagnosing the prostate cancer is prostate specific
antigen (PSA). The first objective of PSA is to group men undergoing treatment to reduce their
mortality rate. Evidences prove that most PSA testing results are correlated with Benign cancer in
which the tumor is not progressive and the cancer is not a threat to the patient (Merrill & Stephen-
son, 2000).
Statistical evidences reveals that false positive is a big portion of the results of PSA tests (about
80 % of false positive rate). Aside the negative psychological impacts on patients, patients with
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false positive are more likely to have biopsy that is an invasive part of treatment and causes reported
fever, bleeding, and infections that are considered as “moderate or major problems” (Rosario et al.,
2012).
To reduce the effects of unnecessary biopsies and overtreatment, the technique in magnetic
resonance imaging, or multi-parametric MRI (MpMRI) is utilized. MpMRI increases the diagnos-
tic capabilities that leads to less biopsies and consequently less side effects. MpMRI combines
anatomic T2W, diffusion-weighted imaging (DWI) and dynamic contrast-enhanced (DCE) MRI to
improve diagnostic capabilities for addressing central challenges in prostate cancer which is critical
for reducing mortality. T2W images are used to discern prostatic zonal anatomy, assess abnormal-
ities within the gland, and to evaluate for seminal vesicle invasion, EPE, and nodal involvement.
Diffusion-weighted imaging (DWI) reflects the random motion of water molecules and is a key
component of the prostate mpMRI exam. It should include an apparent diffusion coefficient (ADC)
map and high b-value images. The ADC map is a display of ADC values for each voxel in an image.
DCE MRI is defined as the acquisition of rapid T1W gradient echo scans before, during and after
the intravenous administration of a low molecular weight gadolinium based contrast agent (GBCA).
T1W images are primarily used to determine the presence of hemorrhages and designed to plot the
gland (Weinreb et al., 2016).
The contrast injection is a part of DCE examination. Prostate cancer is usually multifocal. The
largest tumor focus usually yields the highest Gleason score and is most likely to contribute to extra
prostatic extension (EPE) and positive surgical margins.
In 2012, European Society of Urogenital Radiology (ESUR) introduced a pipeline called PI-
RADS version 1 for scoring system that organizes diagnostic procedure. Later on, due to fast
growing progress the PIRADS v2 was developed.
The objective of MpMRI test is to detect and restrict the area for abnormally related to prostate
cancer. Accordingly, PI-RADS v2 categorizes the lesion of interest into the following five groups:
PI-RADS 1 – Very low (clinically significant cancer is highly unlikely to be present)
PI-RADS 2 – Low (clinically significant cancer is unlikely to be present)
PI-RADS 3 – Intermediate (the presence of clinically significant cancer is equivocal)
PI-RADS 4 – High (clinically significant cancer is likely to be present)
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Figure 3.5: MpMRI, PIRADS v2 classification flow diagram for PZ
Table 3.1: PIRADS v2 Scoring table for MpMRI for PZ
PI-RADS 5 – Very high (clinically significant cancer is highly likely to be present)
The MpMRI results should be interpreted independently and biopsy should be considered only
for PIRADS 4 and 5 and not for PIRADS 1 and 2. Figure 3.5 determines the pipeline for diagnosing.
In case that the score of DWI is 3, the score of DCE acts the main role. A positive DCE may leads
to score the PIRADS from 3 to 4 (Weinreb et al., 2016) as in it shown in Table 3.1. In this case, the
final decision of any further treatment is reserved to the specialist due to the complexity of results
and the decision making process.
MpMRI is the most comprehensive method used in diagnosis for prostate cancer and is the
standard procedure for staging the PC. However it has some drawbacks including high cost, long
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time and use of contrast injection for DCE which causes some discomforts for patients. Therefore,
Biparametric MRI or BpMRI is utilized for overcome these limitations. The BpMRI contains T2W
and DWI. The major different between MpMRI and BpMRI is that the DCE which is omitted in
BpMRI. Elimination of DCE removes the injection of IV contrast from procedure. Injection of IV
contrast agent is costly and leads to patient dissatisfaction. As a result, BpMRI provide the same
services with lower cost and higher satisfaction. However, when it comes to DWI score 3; BpMRI
is unable to lead to the best PIRADS score (Scialpi et al., 2017).
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Chapter 4
Statistical test of dependency between
the result of brain MRI and referring
physician specialization
In this chapter we explain the statistical test we exploited for testing one hypothesis in this thesis.
A statistical test attempts to answer a specific claim about a population parameter based on the
sample data. The intention is to conclude whether there is enough evidence to ”reject” a conjecture
or hypothesis about the process. Alternatively, it may be a disappointing result, indicating we may
not yet have enough data to ”prove” a statement by rejecting the null hypothesis.
4.1 Hypothesis
The very first step of performing a hypothesis test is to define the null and alternative hypotheses.
The null hypothesis is often an initial claim that is based on prior analyses or specialized knowledge.
The alternative hypothesis declares that a population parameter is smaller, larger, or different than
the hypothesized value in the null hypothesis. Accordingly, our null and alternative hypothesis are
defined as follows:
• The incidence of multiple sclerosis (MS) diagnosis based on MRI does not differ between
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patients referred by neurologists and non-neurologists in a community-based practice in a
large metropolitan area in Canada.
• The incidence of multiple sclerosis diagnosis based on MRI differs between patients referred
by neurologists and non-neurologists in a community-based practice in a large metropolitan
area in Canada.
4.2 Variables
Next step is to define the type of data and variables. In general, the data in statistical tests
categorized into three groups:
1. Measurement variables: These variables can be measured like length, pH, and bone density.
2. Nominal variables: are also called attribute variables. These variables classify observations
into a small number of categories. An individual observation of a nominal variable is a name, not a
number. Examples of nominal variables include sex (the possible values are male or female), type
of disease, and blood type.
3. Ranked variables: also called ordinal variables are those kinds of variables that categorizes
data base on the rank or order, even though the exact values are unknown.
Our sample data comes from the healthcare perform center, which is used as a sample to rep-
resents the population of Canada. Based on the null and alternative hypothesis, our variables are
referring physician specialization (neurologist or non-neurologist) and the test result (positive or
negative). Accordingly, the type of variables this thesis is nominal; This leads to a 2x2 contingency
table (Table 4.1).
4.3 Fisher’s exact test
Based on our data and size of the sample (less than 1000) the suitable test of dependent for the
data and variables is Two-tailed Fisher’s exact test of independence. Fisher’s Exact test is a test of
significance which is used in the place of chi-square test in 2 by 2 tables, especially in cases of small
samples. a two-tailed test is a method in which the critical area of a distribution is two-sided and
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Table 4.1: Fisher’s exact test 2 by 2
the test verifies whether or not a sample is greater than or less than a certain range of values.
Fisher’s exact test tests the probability of getting a contingincy table that is as strong due to the
chance of sampling. There are certain assumptions on which the Fisher’s exact test is based. The
sample assumed to be random. It is also assumed that the value of each sample is independent from
other samples value. In other words, the value of one sample does not get affected by the value of
others. Another assumption is mutual exclusively between observations. Accordingly, in our test,
all of the assumptions are met. The contingency Table 4.1 shows the data set for 2x2 variables.
Fisher’s exact test obtains the probability of the combination of the frequencies that are actu-
ally collected. It also includes the finding of the probability of every possible combination, which
designates more evidence of association. This probability (p-value) is calculated as follows:
p = [ ( a + b )! ( c + d )! ( a + c )! ( b + d )! ] / a! b! c! d! N!
In this formula, the a, b, c and d are the individual frequencies of the 2x2 contingency table, and
N is the total frequency.
Significance level
In this study, we consider the significance level for the statistical hypothesis test as 0.05. If the
p-value is less than 0.05, we have enough evidence to reject the null hypothesis; otherwise the null
hypothesis cannot be rejected. Any change in the significance level requires strong and justifiable
reason. With a significance level of 0.05, there is a 5 percent chance of rejecting the null hypothesis,
even if it is true. This is called a ”Type I error” or ”false positive”. If there is a deviation from the
null hypothesis, and the test fails to reject it, that is called a ”Type II error” or ”false negative”.
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­ 
positive negative Total  
Neurologists 9 43 52  
non-neurologists 21 270 281  
Total  30 313 343  
  
Table 4.2: MS incidence data set
We collected the data from Picture Archive and Storage System (PACS) to scan and identify
non-contrast (C-) and contrast-enhanced (C+) MRI of brain related to MS as well as test referring
physician. Out of 343 test results we collected, a total number of 291 patients were referred by
non-neurologists. 21 reports of non-neurologists were positive, and 270 were negative accordingly.
52 patients were referred by neurologists, in which 9 reports were positive, and 43 were negative.
The p-value in our experiment was calculated as 0.029, which means there is a significance
difference between the test results of patients referred by neurologists and non-neurologists. Table
4.2 summarizes the results. These results indicate that devising an MRI protocol of MS diagnos-




Comparison of different MS diagnostic
procedures
5.1 Two-tiered MRI policy with respect to referring physician special-
ization
Brain MRI examinations can be ordered without a pre-authorization or referral from a neurolo-
gist in our community-based practice in (Canada, blinded). Shortly after the release of revised 2010
McDonald’s criteria (Polman et al., 2011), an increase in the number of brain MRI requests was
seen, which explicitly required the contrast of IV and the application of McDonald’s criteria. Brain
MRI can be performed without using the IV contrast, which is a non-sensitive white-water-borne
protein-free protocol. Within a year of accomplishing this particular process, a useful review of
the MRI segment of the brain to rule-out MS was conducted. A meagre percentage of abnormal
(positive) scans in MRIs was seen that are used to evaluate MS in patients undergoing neurological
work. The Brain MRI without contrast (C-), denoted as scenario 2 in this study, needs fewer re-
sources (machine time, technician time, material) and less costly, but it is not accurate as full Brain
MRI with the injection of contrast (C+). We call the C+ protocol as scenario 1 in this study.
Accordingly, we adopted a two-tiered policy where a non-contrast short protocol sensitive to
white matter lesions (C- brain MRI) is used to screen the patients referred by non-neurologists in the
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hope of maintaining accuracy and reducing the cost and increasing efficiency. We call this approach
as scenario 3. In this approach patients referred by a neurologist would undergo an abbreviated
non-contrast brain MRI (C-). If MRI result is negative, MS imaging would be considered complete
in a single hospital visit. If MRI result is positive, patients would enter C+ MRI for an additional
two hospital visits. Patients referred by neurologists, however, would enter C+ MRI directly. This
approach is shown in Figure 5.1.
Figure 5.1: Two-tiered MRI with respect to referring physician specialization for diagnosing MS
5.2 Time-driven activity-based costing in Healthcare
In order to compare the cost of different MRI approaches, we used time-driven activity-based
costing (TDABC) approach. Activity-based Costing (ABC) is the fundamental element of TDABC
which is an excellent way to identify and allocates the costs of overhead activities, and then assign
those costs to products. The ABC System identifies the relationship between costs, overhead activ-
ities, and completed products, and through this relationship, allocates indirect costs to products that
are less arbitrary. However, some costs are difficult to calculate when using this cost accounting
method. Indirect costs, such as wages for personnel and administrators ,are difficult to assign to a
product. Hence, this method has found its way to the manufacturing sector.
The foundation of ABC system of cost accounting is on activities; activity can be an event,
unit of work, or task with a definite purpose, such as designing products, setting up machines for
production, or operating machines (Turney, 1992) & (Cooper & Kaplan, 1991).
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ABC is challenging to implement due to high costs incurred by interviews and surveys required
to setup the initial ABC model. It also suffers from subjective and costly-to-validate time allo-
cations, as well as the problem of maintaining and updating the model as the cost of processes
and resources change overtime. Further, once the initial model is made, model updates need to
be reviewed through a new round of surveys and interviews to reflect changes in the company’s
procedures (Kaplan & Anderson, 2003).
Time-driven ABC addresses all of the above limitations. It is easier, less expensive and faster to
implement, and allows driver costs to be based on practical capability of supplied resources. Time-
driven ABC estimation requires only two parameters: the unit cost of supply and the expected time
for a transaction or an activity.
TDABC method uses an estimate of the time required each time the activity is performed. This
one-time estimate replaces the interview process with people to learn how much time they spend on
all activities in a dictionary. Time estimation can be achieved by direct observation or interviews.
High precision is not required at this stage; a general estimation is sufficient (Kaplan & Anderson,
2007).
TDABC in healthcare is primarily used to estimate the cost of clinical practices and visits in
order to inform operational improvement and compare them with reimbursement tariffs. TDABC
programs varied, but in general, it involves the following the seven-steps model reflected (Keel,
Savage, Rafiq, & Mazzocato, 2017):
Step 1. Select the medical condition
Step 2. Describe the care delivery value chain
Step 3. Develop process maps for each activity in patient care delivery
Step 4. Obtain time estimations for each process
Step 5. Measure the cost of providing patient care resources
Step 6. Measure the capacity of each resource and calculate the capacity cost rate
Step 7. Calculate the total cost of patient care
The purpose of this study is to provide the best quality care to the patient at the lowest overall
cost in brain MRI for diagnosing MS. Not every TDABC is the same, nor all of its terms apply to
every project. We defined the steps of this study inspired by TDABC approach. The main difference
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of this study with TDABC method, is the scale of the project. In the majority of studies on the
application of the TDABC in a healthcare project, medical condition is in the center of attention and
all the values are defined to optimize the procedure of curing that medical condition. However, the
purpose of our study is to provide -or maintain- the best quality at the lowest cost in the procedure
of diagnosing the disease. Therefore, some steps of TDABC approach, such as describing the care
delivery value chain, which starts from monitoring and preventing and continues to intervene and
recovering, are not take into consider action.
5.3 Data collection
In this study, we defined and later collected five types of data, including patient-related data,
MRI protocol’s data, MRI results, cost and, adverse events’ data. With accessing this data, we are
able to map different MRI diagnostic procedures and compare them in term of different performance
indicators. The detailed description of each type of data along with its features and the method of
data collection are provided in the following sections.
5.3.1 Patient
With the absence of searchable radiology or hospital information system (RIS, HIS), to acquire
patients’ data for diagnosing MS, Picture Archive and Storage System (PACS) was used to scan
and identify all the patients with either non-contrast (C-) or contrast-enhanced (C+) MRI of brain.
All patients with results containing any or combination of ”rule out”, ”Multiple Sclerosis”, ”MS”,
”demyelination”, ”demyelinating disease” and, ”McDonald’s criteria” were counted as inclusion
criteria. Exclusion criteria split into 4 categories:
1. Patients with a previous/known diagnosis of MS (either first scan or follow-up)
2. Patients with prior abnormal CT scan suspicious for demyelinating disease based on history
or radiology report.
3. Patients with a test history containing any or combination of ”follow-up, Headache / Mi-
graine, Lesion, Vertigo, Ataxia, Dizziness, Tremors, Nausea, TIA, Stroke, Syncope, Memory loss,
Dementia, Alzheimer’s, Cognitive, Decline, Deterioration”, without keywords included in inclusion
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criteria.
4. Patients with brain MRIs performed with specific protocols (identifiable on PACS, e.g. MRI
IACs, C- MRA).
Data related to patients as gender and age were also collected. MRI services are not offered to
patients younger than 18 years old or younger in this hospital.
5.3.2 MRI protocol
All data related to brain MRI protocol, such as the number of sequences in each protocol and
presence or absence of IV contrast were collected. Base on protocol exam card, an average scan per
sequence time were calculated. Manual extraction of pre-exam scan times based on individual exam
time-stamps on PACS was hardly possible; therefore, we did not obtain it. Two MRI technologists
with more than 7 years of MRI scanning experience in the hospital estimated the average MRI room
time. Referring physician specialization’s data were collected using the online physician directory
of Colle`ge des Me´decins du Que´bec. Clinical referrals were sorted into two categories: neurologists
and non-neurologist.
5.3.3 MRI results
To obtain the MRI results, a master student in Industrial Engineering was trained by a radiologist
with 6 years of mixed academic and community practice experience to search in the PACS and
obtain and evaluate clinical information for all inclusion and exclusion criteria and also evaluate the
finalized report. Any inconclusive report was reviewed and classified by the radiologist.
5.3.4 Cost
From healthcare system perspective, all costs related to the protocol, such as MRI operational
cost, including salaries (technologists, secretary), service contract, contrast administration cost,
costs associated with renal function tests before contrast administration and radiologist professional
fees, were obtained. From the patient’s perspective, the costs were parking expenses and loss of
productivity for half a day for each test. No other costs are incurred by the patients during visits due
to 100% insurance coverage in Canada.
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5.3.5 Adverse events
An effort was made to account for patient experience given the invasive nature of both venipunc-
ture and IV contrast administration. We collectively termed these complications as ”adverse events”
leading to a less than satisfactory patient experience. The true incidence of venipuncture compli-
cations is not known given retrospective nature of the study. Patient records for documentation of
contrast reactions were also not studied, nor a measure of patient experience such as satisfaction
surveys. We ignored patient dissatisfaction from staying longer in the magnet bore during C+ MRI,
and rare (0.05%) (AmericanCollegeOfRadiology et al., 2015) contrast extravasation.
Non-tangible expenses such as radiologist interpretation time, loss of time or personal produc-
tivity to patients as well as discomfort and complications due to phlebotomy IV contrast adminis-
tration were considered but could not be translated to financial value reliably.
5.4 Comparison Parameters
After mapping different approaches and obtaining data related to them, defining parameters
for comparison is the next step. With proper parameters that can be measured and compared, the
protocols would be ready to analyze. Parameters can be categorized as cost (system and patient’s
perspective), service performance, and service value. Hence, these parameters were defined, calcu-
lated and compared as:
1. (Health) System cost: This is the cost of MRI utilization plus renal testing. System cost is
the main portion of expenses as all the costs in public health care are covered by health insurance.
System costs are classified into two subgroups:
a. System cost per completed MRI workup no matter what the results are.
b. System cost per positive MRI.
2. Total patient cost: This is the cost of parking and loss of productivity for half a day (per
test) for patients. As we mentioned before, in Canada, due to 100 % insurance coverage, patients
would not pay for medical tests. We consider the following subgroups for patient cost:
a. Patient cost per completed MRI workup
b. Patient cost per positive MRI
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3. (Health) Service Performance: The service performance is measured in terms of the fol-
lowing parameters:
a. Throughput: Time required to complete MRI workup (target outcome)
b. Number of callbacks
c. Number of estimated adverse events
d. Percentage of patients with less than satisfactory MRI experience after complete MRI workup
for all patients
e. The number needed to harm (NNH): this number is an epidemiological measure that indicates
the harm or adverse effects. It indicates how many people should be exposed to the risk factor in a
given period in order to cause harm an average of one person who otherwise would not have been
harmed. It is defined as the inverse of the absolute risk increase and calculated as 1/(EER-CER),
where EER is the incidence in the treated (exposed) group, and CER is the incidence in control
(unexposed) group. Intuitively, lower the number needed to harm means worse risk factor, and
when it is equal to 1, it means that every exposed person is harmed (Porta, 2014).
The MS scenario 2 (abbreviated protocol) will be considered as the control groups given their
lowest rate of adverse events. Two sets of NNHs will be calculated: Once calculating adverse
events for both venipuncture and contrast and once calculating only contrast complications. The
reason for the latter is to assess the significance of taking venipuncture complications into account,
not previously addressed in MRI economics literature to the best of our knowledge.
4. MRI Service Value:
a. Value is defined using Baldor’s formula as (Quality x Service)/(Cost x Time)
i. Quality is defined as the diagnostic outcome of individual MRIs and is considered constant
between all MRI scenarios (similar accuracy of MRI interpretation by the radiologists). Service is
defined as the inverse rate of adverse events.
ii. Cost is defined as the total of system and patient’s costs.
iv. Time is the same as throughput
b. Service value will be calculated for and compared between different MRI scenarios.
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5.5 Results
A total of 4812 C- and C+ MRIs were identified in the initial PACS query. 343 cases were
relevant to our study with a mean age of 42.3 (age range 18-85). A total number of 291 patients
were referred by non-neurologists. 21 reports of non-neurologists were positive, and 270 were
negative accordingly. 52 patients were referred by neurologists, in which 9 reports were positive,
and 43 were negative.
All studies were performed on a 1.5T Siemens Avanto magnet (Siemens AG, Munich, Ger-
many). Table 5.1 shows the C- and C+ protocol sequences and average scan time and average room
time based on MRI technologist estimate. Total room time compared to acquisition time is longer
for C+ versus C- MRI ( 13 vs. 8.5 min) due to the additional time required to establish IV access.
Table 5.1: C+ and C- MRI Protocols, acquisition and room times
From a total of 104 referring clinicians, 13 were neurologists (12.5 %) and 91 non-neurologists
(87.5 %). Of the non-neurologists, 68 were General Practitioners (GPs) and 23 non-neurologist
specialists [(internal medicine (n=11), general and specialized surgery (n=4), anesthesiology (n=1),
ophthalmology (n=1), emergency medicine (n=1), Physical medicine and rehabilitation (n=2), Rheuma-
tology (n=1), Hematology (n=1), Anesthesiology (n=1)].
27
MRI accessibility
At our hospital, similar to most MRI services, we are unable to offer C- and C+ exams equally
throughout the day since C+ MRIs require presence of a licensed individual. At this hospital C+
MRIs are only performed from 7:30am to 2:30pm (7 hours), with the remaining 8 hours limited to
C- MRIs. In one workday (7h x 60min / 35min =) only 12 C+ MRIs can be performed, while the
number of C- MRIs can reach (15h x 60min / 15min =) 60. Combining the two studies will allow
12 C+ MRIs and an additional (8h x 60min / 15min =) 32 C- MRIs, for a total number of 44 patients
per day.
Table 5.2 shows the time to complete the diagnostic services required for this patient cohort,
longest in scenario #1. Scenario #2 is most efficient, rendering the service in 8.21 days, while it
takes 3.48 times longer for scenario #1 to complete the service.
Table 5.2: Time required to complete MRI workup for all patients referred to rule out MS
For simplicity, this is calculated with the conservative assumption that the callback protocol is
the same as the initial C+ study (35 min room time) and therefore underestimates the efficiency of
scenario #2. Practices can further shorten the acquisition time for callback C+ MRIs by acquiring
only the ”missing” sequences, increasing the efficiency of scenarios #2 and #3.
5.5.1 Adverse events
In absence of objective data in our patient cohort, we used the literature to estimate the preva-
lence of adverse events related to IV contrast and venipuncture. The latest edition (V10.3, 2018) of
ACR manual on contrast media [10] reports that “adverse event rate for Gadolinium based contrast
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agents (GBCAs) administered at clinical doses (0.1–0.2 mmol/kg for most) ranges from 0.07 % to
2.4 %”. We used the arbitrary average of the range extremes for an estimate complication rate of
[(0.07+2.4) / 2 =] 1.2 %. We noted and did not choose the much lower rates of adverse reactions
had been reported for ProHance and MultiHance (0.003 %) from the EuroCMR Registry (Bruder
et al., 2011) as they pertained to a potentially different population.
Venipuncture adverse events, in light of paucity of literature on this topic, were estimated from
a 1992 study (Dale & Howanitz, 1996), the 1991 report of “College of American Pathologists Q-
Probe study of patient satisfaction and complications” (Howanitz, Cembrowski, & Bachner, 1991)
and its 1996 update (Dale & Howanitz, 1996). In the latter two reports, patient dissatisfaction were
mainly due to post-venipuncture bruising or need for more than one needle stick. Bruise rates in
these studies were 12.3 %, 16.6 % and 12.9 %, respectively, averaged to [(12.3+16.6+12.9) / 3 =]
14 %. The rate for more than one needle stick was 3 % in the 1995 report, and not specified in the
other studies. The cumulative adverse event rate for venipuncture was calculated as (14 + 3 =) 17
%. We do note that these two rates are definitely not additive (patients requiring more attempts are
more likely to get bruises), however, this overestimation may be balanced by ignoring less common
complication rates, such as “serious complications” in 3.4 % (Dale & Howanitz, 1996) and syncope
in less than 1 % (Organization et al., 2010).
Therefore, a C+ MRI would expose the patient to 17 % adverse events during renal testing
venipuncture and (17 % + 1.2 % =) 18.2 % adverse events due to second venipuncture and contrast.
5.5.2 Cost
System’s expenses
In absence of established MRI price/cost data, three sources were considered:
1) Price in Montreal’s private MRI clinics.
2) Direct Pay Fee charged by our public hospital to individuals who do not have public health
insurance.
3) Cost in public hospital for patients with health insurance according to MRI operational budget
of the department, calculated as below:
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a. Annual MRI operational cost: $ 1,569,274
b. Annual MRI operation: 3900 hours (15 hours/day, 5 days/week)
c. MRI operation cost per hour: $ 402.38 and per minute: $ 6.71
As most MRI services are offered in the public hospitals to insured patients, the last estimate
were used for cost analysis. Other expenses include:
1) Contrast cost [one bottle of IV contrast ($ 15) plus phlebotomy ($ 2.17 = needle $ 1.15 + IV
line cap $ 0.88 + dressing $ 0.14)]: $ 17.17.
2) Renal function test: $ 3.23.
3) Radiologist professional fees: $ 105.
Patient’s expenses
Based on average daily income of $ 221.5 (252 work days/year, average annual salary of $
55820 in city of (Blinded), each hospital visit incurs a half day income loss of $ 110.8, in agreement
with estimates in a recent similar study (Pahwa et al., 2017). Parking fee is $ 20 per hospital visit.
Non-tangible costs include patient anxiety due to call back. The call backs are always performed
within a week, so the delay in diagnosis is considered negligible. All costs related to patients and
system are summarized in Table 5.3.
5.5.3 Decision tree results
As we mentioned earlier, three scenarios were included in this study: 1) The patient would
undergo a contrast-enhanced brain MRI (hereafter referred to as C+). This will require two visits to
the hospital: one for renal function testing and one for the MRI examination. The results of renal
functions test are not available the same day at this hospital for outpatients. Figure 5.2 shows the
total cost of 343 patients, and adverse patient experience for the renal function test and C+ MRI test.
The total system cost in Scenario 1 for 343 patients is 123,514.30 $. Total patient cost is 89,728.80
$. The total portion of adverse patient experience is 35 %. Table 5.4 summarizes all the costs related
to each visit in scenario 1. The system cost per MRI in this scenario is 360.10 $ as well as the patient
cost is 261.60 $.
1Radiologist professional fee is waived for the recall exam
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Table 5.3: System and patient costs1
2) The patient would undergo an abbreviated non-contrast brain MRI (hereafter referred to as C-
). If MRI result is negative, MS imaging would be considered complete in a single hospital visit. If
MRI result is positive, patients would enter scenario #1 for an additional two hospital visits. Figure
5.3 shows the total cost of 343 patients, and adverse patient experience for C- MRI test, the renal
function test, and C+ MRI test. The total system cost in Scenario 2 for 343 patients is 78,173.80
$ .The total patient cost is 52,712.40 $. The total portion of adverse patient experience is 3.09 %.
Table 5.5 summarizes all the costs related to each visit in scenario 2. The system cost per MRI in
this scenario is 227.91 $ as well as the patient cost is 153.68 $.
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Figure 5.2: Scenario #1
Figure 5.3: Scenario 2
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Table 5.4: Scenario 1 Cost
Table 5.5: Scenario 2 Cost
3) Patients referred by a neurologist would enter scenario 1, patients referred by non-neurologists
would follow scenario 2. Figure 5.4 shows the total cost of 343 patients, and adverse patient expe-
rience for C- MRI test, the renal function test, and C+ MRI test. The total system cost in Scenario
2 for 343 patients is 83,911.90 $ .The total patient cost is 54,412.80 $. The total portion of adverse
patient experience is 7.5 %. Table 5.6 summarizes all the costs related to each visit in scenario 2.
The system cost per MRI in this scenario is 244.64 $ as well as the patient cost is 158.64 $.
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Figure 5.4: Scenario 3
Table 5.6: Scenario 3 Cost
5.6 Discussion
Decision Tree Analysis
The Institute for Healthcare Improvement (IHI) Triple Aim initiative is a structure that defines
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an approach in order to optimize health system performance. The so-called ”Triple Aim” seeks to:
1) improve patient experience (including quality and satisfaction),
2) improve the population’s health, and
3) reduce per capita cost of healthcare.
We will compare the three MRI scenarios with these aims that we will call IHI’s Aim 1, Aim 2,
Aim 3 for the sake of simplicity.
The MS MRI scenario 2: imposes the least direct expense on patients and has the least num-
ber of adverse effects but the highest callback. It is likely that venipuncture- and contrast-related
complications adversely affect patient experience more than call back anxiety. Nevertheless, we
ascribed them equal weight towards the total number of unpleasant experiences. Scenario 2 remains
the lowest among the three scenarios, meeting IHI’s Aim 1. With the lowest number of adverse
events, it meets IHI’s Aim 2 compared to other scenarios. It is the most cost-effective strategy,
meeting IHI’s Aim 3.
The current standard of practice (scenario 1) imposes the highest cost on both the health sys-
tem (+ 58%) and patients (+ 70%), while suffering from the least efficient throughput, inflicting a
tremendous number of adverse events (11.3 times higher than scenario 2), has the lowest number
(worst) needed to harm and offers the least service value (table 5.7). Hence, it does not meet any of
IHI’s Aims.
Table 5.7: Comparison of MRI Service Value in different scenarios
The performance of scenario 3 is in between the other two scenarios, pretty close to Scenario 1.
We considered this scenario since patients referred by neurologists are expected to have the highest
pre-test probability of having MS, and we postulated that the rate of positive MRI results in these
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patients would affect the performance of each scenario.
In our population of 17% MRI positive in patients referred by neurologists, scenario 2 is still the
most cost-effective option compared to other scenarios. Nevertheless, with a different positive rate
for neurologists patients, scenario 3 could be more cost-effective. Given the extreme 100% positive
MRI rate in neurologists patients in Scenario 2, it is necessary to callback all these patients, and
each neurologists patient will have to receive both C- and C + MRI, affecting all measured variables
negatively.
It has been shown that the participation of academic neuroradiologists in the utilization manage-
ment program results in a reduction of 20% in additional studies using appropriate criteria. Scenario
2 is similar to a series of interventions in a program without pre-authorization programs not only
on eligibility criteria but also on the economics of MRI technology (a.k.a. MR economics) (Bell,
1996). In a follow-up study in 2016, Friedman and Smith reported that radiologist involvement
had a significant impact on a collaborative utilization management program. The highest impact
was related to family practice (42.7%), internal medicine (41.8%), and neurology (33.4%), which
constituted 104/92 (88.8%) of the referring clinician referred to this study ( 68, 11, 13 sequentially).
They concluded that this outcome was independent of the provider’s expertise. On the other hand,
Scenario 3 shows that considering the expertise of the service provider has a significant impact on
the service parameters.
This is the first important conclusion of our study: that expertise of the referring clinician, by
affecting the likelihood of a positive pre-test result, can serve as a decision node for two- or multi-
tiered protocols. To the best of our knowledge, this effect has not been described in the literature
before.
The Patient Perspective
We have already noted that Scenario 1 imposes the highest direct costs to patients and the highest
rate of adverse events, albeit without any callback. Callbacks are considered undesirable for two
reasons: 1) by most imaging facilities, they are considered to disrupt workflow, and 2) they are
associated with patient anxiety as well as discomfort and dissatisfaction.
We calculated that scenario 1 would require 3.11 times more time to complete the diagnostic
services needed for this patient group (Table 5.9). This means that in multi-tiered approaches,
36
Table 5.9: Number needed to harm, using scenario 2 as the control group
callback should not be dismissed or minimized, but optimized.
Table 5.8: Summary of cost, service performance, patient experience and value analysis Coloured
numbers in parentheses in scenarios 1 and 3 cells represents comparison to scenario 2
Phlebotomy is an underestimated procedure: Table 5.8 illustrates the number needed to plum-
mets falls from 91.32 to 3.13 when considering venipuncture complications.
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Chapter 6
Comparison of different PC diagnostic
procedures
In this chapter, we first introduce a two-tiered MRI scenario for diagnosing PC. Then, we com-
pare two scenarios base on cost and efficiency.
6.1 Two-tiered MpMRI policy
In order to overcome the limits of BpMRI and the cost and dissatisfaction rate of MpMRI
(chapter 3), a two-tiered MpMRI was introduced. In this procedure, all patients take a BpMRI.
Patients with PIDADS score (DWI) of 1, 2, 4 and 5 do not need to come back for further MRI tests
due to the certainty of the results for these scores. However, all patients with a DWI score of 3
need to come back for another test, which would be MpMRI to determine their PIRADS score. The
proposed Two-tiered MpMRI is shown in Figure 6.1.
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Figure 6.1: Two-tiered MpMRI, PIRADS v2 classification flow diagram for PZ
6.2 Data collection
Similar to the MS MRI study (chapter 5), we defined and later collected five types of data,
including patient-related data, MRI protocol’s data, MRI results, cost and, adverse events’ data.
With accessing this data, we can map the PC diagnostic procedures for different approaches and
compare them through different parameters. We explain each type of data, its features and the
method of a data collection below.
6.2.1 Patient
Patients’ data is abstracted from the electronic medical record (EMR) for all patients included
in this study by a trained researcher. The researcher reviewed the MRI reports and isolated the
portion related to PC disease and assigned Prostate Imaging Reporting and Data System (PI-RADS)
categories. Patients’ age, allocated MRI time, overall PIRATES results, TZ score, PZ score, DWI
score for PZ and Referring MD are collected. The patients’ results were categorized as positive and
negative groups. A positive category means the findings on the MpMRI report were a likely cause
of PC based on PIRATES V2 (Scores 3, 4 and 5). All patients with overall PIRATES score of 1 and
2 are categorized as negative. Patients with positive results are considered to have the disease and
patients with negative results are assumed to be disease-free as it is shown in Table 6.1.
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Table 6.1: Definition of having disease and disease-free based on PIRADS score
6.2.2 MRI protocol
All data related to PC MRI protocol such as the pre-tests need to be performed, presence or
absence of IV contrast and, the sequences of the tests were collected. Due to the lack of information,
we were unable to estimate the scanning time of BpMRI and MpMRI.
6.2.3 MRI results
To obtain the MRI results, a Master’s student in Industrial Engineering was trained by a radiol-
ogist with 6 years of mixed academic and community practice experience (blinded) to search in the
PACS and obtain and evaluate clinical information for all inclusion and exclusion criteria and also
evaluate the finalized report. Any inconclusive report was reviewed and classified by the radiologist.
6.2.4 Cost
Similar to previous chapter, the main perspectives are the healthcare system and patient. From
the healthcare system perspective, all costs related to the protocol, such as MRI operational cost
including salaries (technologists, secretary), service contract, contrast administration cost, costs as-
sociated with renal function tests before contrast administration and professional radiologist fees,
were obtained. From the patient’s perspective, the costs were parking expenses and loss of produc-
tivity for half a day for each test. No other costs are incurred by the patients during visits due to
100% insurance coverage in Canada.
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6.2.5 Adverse events
The nature of adverse events is identical with adverse events in chapter 5.
6.3 Comparison Parameters
After mapping MRI protocols (Chapter 3) and obtaining data related to them, modeling param-
eters for comparison is the next step. With proper parameters that can be measured and compared,
the protocols would be ready to analyze. Parameters can be categorized as cost (system and patient’s
perspective), service performance, and service value. These parameters are defined as follows:
1. (Health) System cost: This is the cost of MRI utilization plus renal testing. System cost is
the main portion of expenses as all the costs in public health care are covered by health insurance.
Subgroups:
a. System cost per completed MRI workup no matter what the results are.
b. System cost per positive MRI.
2. Total patient cost: This is the cost of parking and loss of productivity for half a day (per
test) for patients. As we mentioned before, in Canada, due to 100 % insurance coverage, patients
would not pay for medical tests. These costs are classified into two subgroups:
a. Patient cost per completed MRI workup
b. Patient cost per positive MRI
3. (Health) Service Performance:
a. Number of callbacks
b. Number of estimated adverse events
c. Percentage of patients with less than satisfactory MRI experience after complete MRI workup
for all patients
d. The number needed to harm (NNH)1
4. MRI Service Value:
a. Value is defined using Baldor’s formula as (Quality x Service)/(Cost x Time)
1Defined in chapter 5
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i. Quality is defined as the diagnostic outcome of individual MRIs and is considered constant
between all MRI scenarios (similar accuracy of MRI interpretation by the radiologists). Service is
defined as the inverse rate of adverse events.
ii. Cost is defined as the multiplication of system and patient costs.
iv. Time is the same as throughput (it is constant for PC)
b. Service value will be calculated for and compared between scenarios.
6.4 Results
A total number of 145 patients were studied, including 10 cases of PIRADS 5, 13 cases of
PIRADS 4, and 6 cases of PIRADS 3. Among those with PIRADS 4, there were 2 cases with DWI
score of 3 and their overall PIRADS score was upgraded to 4 based on positive DCE. All other 116
cases were negative with PIRADS 2. We had no cases with negative results and PIRADS 1.
According to the data, 80 % of cases were directly negative (PIRADS score 1 or 2), 14.5 %
are directly positive (PIRADS score 4 or 5) and 5.5 % are results with DWI score of 3. Among
those cases with PIRADS 3, 25 % upgraded to PIRADS 4 based on the DCE positive results as it
is illustrated in Figure 6.2. All studies were performed on a 1.5T Siemens Avanto magnet (Siemens
AG, Munich, Germany).
6.4.1 Adverse events
The nature of adverse events in MpMRI is similar to Brain MRI (renal function test adverse
events and contrast injection adverse events). Therefore, a MpMRI would expose the patient to 17
% adverse events during renal testing venipuncture and (17 % + 1.2 % =) 18.2 % adverse events due
to second venipuncture and contrast.
6.4.2 Cost
All the costs related to the healthcare system and patients are similar to MS MRI costs. Table
6.2 shows these these costs.
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Figure 6.2: Two-tiered MpMRI, PIRADS v2 classification flow diagram for PZ with the rate of each
result score
System’s expenses
In absence of established MRI price/cost data, three sources were considered:
1) Price in Montreal’s private MRI clinics.
2) Direct Pay Fee charged by our public hospital to individuals who do not have public health
insurance.
3) Cost in public hospital for patients with health insurance according to MRI operational budget
of the department, calculated as below:
a. Annual MRI operational cost: $ 1,569,274
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b. Annual MRI operation: 3900 hours (15 hours/day, 5 days/week)
c. MRI operation cost per hour: $ 402.38 and per minute: $ 6.71
As most MRI services are offered in the public hospitals to insured patients, the last estimate
were used for cost analysis. Other expenses include:
1) Contrast cost [one bottle of IV contrast ($ 15) plus phlebotomy ($ 2.17 = needle $ 1.15 + IV
line cap $ 0.88 + dressing $ 0.14)]: $ 17.17.
2) Renal function test: $ 3.23.
3) Radiologist professional fees: $ 105.
Patient’s expenses
Based on average daily income of $ 221.5 (252 work days/year, average annual salary of $
55820 in city of (Blinded), each hospital visit incurs a half day income loss of $ 110.8, in agreement
with estimates in a recent similar study (Pahwa et al., 2017). Parking fee is $ 20 per hospital visit.
Non-tangible costs include patient anxiety due to call back. The call backs are always performed
within a week, so the delay in diagnosis is considered negligible.
6.4.3 Decision tree results
Two scenarios have been taken into consiteration as follows:
Scenario 1: 145 patients would visit the hospital twice. The first visit is for renal function
testing, and the second visit is for MpMRI. There is no callbacks required. Figure 6.3 shows the
total cost of 145 patients, and adverse patient experience for the renal function test and MpMRI test.
The total system cost in Scenario 1 for 145 patients is 52,214.50 $. Total patient cost is 37,932 $.
The total portion of adverse patient experience is 35.2 %. Table 6.3 summarizes all the costs related
to each visit in scenario 1. The system cost per MRI in this scenario is 360.10 $, where as the patient
cost is 261.60 $.
Scenario 2: 145 patients would visit the hospital once to undergo BpMRI. 116 with negative
MRI complete their workup (PIRADS 1 & 2). 21 with positive MRI also complete their workup
(PIRADS 4 & 5). 8 patients with PIRADS 3 would visit the hospital twice more. The first visit
1Radiologist professional fee is waived for the recall exam
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Table 6.2: System and patient costs
is for renal function testing, and the second visit is for MpMRI. Figure 6.4 shows the total cost of
145 patients, and adverse patient experience for the renal function test and MpMRI test. The total
system cost in Scenario 1 for 145 patients is 31,852.80 $. Total patient cost is 21,058.80 $. The
total portion of adverse patient experience is 1.94 %. Table 6.4 summarizes all costs related to each
visit in scenario 2. The system cost per MRI in this scenario is 219.67 $ as well as the patient cost
is 145.23 $.
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Figure 6.3: Scenario #1 decision tree
Figure 6.4: Scenario 2 decision tree
46
Table 6.3: Scenario #1 cost
Table 6.4: Scenario 2 cost
We also compare the two MRI scenarios with three IHI’s aims:
1) improve patient experience (including quality and satisfaction),
2) improve the population’s health, and
3) reduce per capita cost of healthcare.
The PC MRI scenario 2: has the least number of adverse effects but the highest callback. As we
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discussed in chapter 5, the contrast-related complication negatively affects patient experience more
than call back anxiety. Scenario 2 imposes the least direct expense on patients. Scenario 2 remains
the lowest among the two scenarios, meeting IHI’s Aim 1. With the lowest number of adverse
events, it meets IHI’s Aim 2 compared to the other scenario. It is the most cost-effective strategy,
meeting IHI’s Aim 3.
The current standard of practice (scenario 1) imposes the highest cost on both the health system
(+ 63%) and patients (+ 80%), while suffering from inflicting a tremendous number of adverse
events (18 times higher than scenario 2), has the lowest number (worst) needed to harm and offers
(table 6.6) the least service value (table 6.7). It does not meet any of IHI’s Aims.
Table 6.5: Summary of cost, service performance, patient experience and value analysis
Table 6.6: Number needed to harm, using scenario #2 as the control group
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Table 6.7: MRI Service Value
The Patient Perspective
We have already noted that Scenario 1 imposes the highest direct costs to patients and the
highest rate of adverse events, albeit without any callback. However, the average number of visits
in scenario 1 is 2 visits and in scenario 2 is 1.11 visits which is less than scenario 1. Callbacks are
considered undesirable for two reasons: 1) by most imaging facilities, they are considered to disrupt
workflow, and 2) they are associated with patient anxiety as well as discomfort and dissatisfaction.
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Chapter 7
Conclusion and future work direction
This chapter concludes the thesis by providing a summary of key findings and contributions in
the thesis. Some future directions of research are also provided.
7.1 Summary of Contributions
The main contributions of the thesis can be summarized as follows.
1. Dependency between the result of brain MRI and referring physician specialization: by
exploiting Fisher’s exact test, the result obtained was that there is a significance difference between
the test results of patients referred by neurologists and non-neurologists.
2. Mapping MS and PC MRI procedures: throughout our study, we mapped MS and PC
MRI procedures. All data related to costs, specialist and machine, and materials needed for these
procedures were collected. We used this information to compare different scenarios in terms of
cost, efficiency, throughput, and number of adverse events. These maps can be used later for further
research in the field of diagnostic procedures.
3. Comparison of different MS MRI approaches: a new approach was proposed which
respects referring physician specialization was proposed. We compared three different MRI pro-
cedures in terms of IHI’s aims. The current practice of diagnosing MS shows to be missing all
IHI’s aims compare to other approaches. The two-tiered scenario showed to be promising in all
IHI’s aims. It decreased the per capita cost of MRI procedure, increased patients’ experience and
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improved the population’s health. Although the third scenario, which was based on referring physi-
cian specialization, could not provide the best performance and cost-efficiency, under different cir-
cumstances (i.e. the higher rate of positive results for neurologist patients), it could be the best
option.
4. Comparison of different PC diagnostic procedures: we compared two MRI procedures
for diagnosing PC; MpMRI and two-tiered MpMRI. In this part of the project, we compared these
approaches in terms of 3 IHI aims. As a result, two-tiered MpMRI turned out to be the best op-
tion in all IHI’s aims. Two-tiered MpMRI showed to be cost-efficient and reduced the number of
callbacks and venipuncture, contrast complication, and consequently. reduces patients’ anxiety and
dissatisfaction.
5. Improving utilization and healthcare service: by adopting two-tiered scenario for both
studies (MS and PC) we reduced patients’ throughput and waiting time. We also reduced the number
of sequences which leads to higher radiology efficiency, resulting in less busy physicians, more
accessible radiologist, and faster report turn-around time.
7.2 Future Work
The existing study can be extended into the following directions:
• The two-tiered procedure with respect to referring physician specialization can be used for
PC diagnostic procedure as well. However, the setting might be different, but it worth to try.
• More complicated classification models shall be tried out. In this thesis, we studied the two-
tiered method and two-tiered with respect to referring physician specialization. There are
other scenarios for multi-tiered that could be further investigated.
• Implementing the same method on other disease diagnostic procedures. There is an infinite
number of diseases that are diagnosed with full MRI procedures. The two-tiered or multi-
tiered MRI procedure can be investigated for those diseases as well (Oldrini et al., 2018) &
(Paolini et al., 2013).
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• Sample size computation is an essential aspect of comparison analytics. Increasing the num-
ber of sample size could lead to more reliable and valid results.
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